Senior Consultant
Mr. Kenneth Stokholm has over 30 years of experience in the life sciences, combining 16 years as Chief Executive Officer of a global CDMO group with more than 12 years of board assignments across Sweden, the Netherlands, and the United States. As CEO of Sever Pharma Solutions, he scaled revenues sixfold, led the group’s expansion into the United States, and built sustainable profitability. On his boards, he has contributed to portfolio strategy, capital allocation, and stakeholder management across both group-related and independent companies, bringing governance expertise in strategy, M&A, and risk oversight backed by a track record of turnaround, growth, and international expansion across five countries. Mr. Stokholm holds a Board Director certification from IMD, an MSc in Biotechnology from the Technical University of Denmark, and an Executive MBA from HEC Paris.